pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Phosplatin therapeutics is a clinical stage pharmaceutical company developing phosphaplatins, a family of small-molecule compounds with an attractive safety profile and unique molecular pharmacodynamic properties.
LOCATION
New York, NY, USA
THERAPEUTIC AREAS
Oncology
WEBSITE
https://phosplatin.com/
CAREER WEBSITE
None
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
May 5, 2022
Phosplatin Therapeutics Adopts New Corporate Name as Promontory Therapeutics Inc.
Apr 13, 2022
Phosplatin Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of PT-112 for Thymoma and Thymic Carcinoma in Collaboration with National Cancer Institute
Apr 11, 2022
Phosplatin Therapeutics Reports on PT-112's Selective Effects and Immunogenic Cell Death in Human Prostate Cancer Cell Models at the AACR Annual Meeting 2022
Mar 24, 2022
Phosplatin Therapeutics Appoints Lorenzo Galluzzi, PhD, a Pioneer in Immunogenic Cell Death Research, to Scientific Advisory Board
Mar 10, 2022
Phosplatin Therapeutics Presents on PT-112 at the 2022 AACR Annual Meeting: Selective Intracellular Effects Leading to Immunogenic Cell Death (ICD) in Prostate Cancer Cell Models
For More Press Releases